Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
clinical trials
3
×
drugs
life sciences
national blog main
new york blog main
new york top stories
svb leerink
3
×
amgen
biotech
boston top stories
fda
marc goodman
national top stories
alder biopharmaceutical
alirocumab
allergan
allopregnanolone
alnylam pharmaceuticals
american academy of neurology
atogepant
biohaven
bob azelby
boston
botox
boulder/denver blog main
boulder/denver top stories
brexanolone
brian abrahams
calcitonin gene-related peptide
detroit blog main
detroit top stories
eli lilly
eptinezumab
erenumab
evercore isi
evolocumab
fremanezumab
galcanezumab
heart attack
What
drug
new
3
×
fda
alnylam
approval
approved
arguments
based
big
brexanolone
cholesterol
class
commercialized
companies
competitors
data
decades
depression
devastating
disorder
drugs
evidence
fast
heart
lasting
long
looms
lowering
make
medco
medicine
medicines
meeting
migraine
moms
neuro
oks
oral
partner
partum
Language
Current search:
new
×
" clinical trials "
×
" svb leerink "
×
@xconomy.com
5 years ago
MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
FDA OKs Depression Drug For New Moms: Fast Relief But Tough to Take